Kevin M. Pohlman - Sep 30, 2021 Form 4 Insider Report for PATTERSON COMPANIES, INC. (PDCO)

Role
President - Animal Health
Signature
Les B. Korsh, by Power of Attorney
Stock symbol
PDCO
Transactions as of
Sep 30, 2021
Transactions value $
$2,173
Form type
4
Date filed
10/4/2021, 04:03 PM
Previous filing
Aug 10, 2021
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PDCO Common Stock Award $2.17K +73 +0.07% $29.77 98.8K Sep 30, 2021 Direct F1, F2, F3
holding PDCO Common Stock 1.66K Sep 30, 2021 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PDCO Employee Stock Options 18.9K Sep 30, 2021 Common Stock 18.9K $30.77 Direct F5, F6
holding PDCO Employee Stock Options 24.8K Sep 30, 2021 Common Stock 24.8K $23.57 Direct F7, F8
holding PDCO Employee Stock Options 33.8K Sep 30, 2021 Common Stock 33.8K $22.25 Direct F9, F10
holding PDCO Employee Stock Options 13.3K Sep 30, 2021 Common Stock 13.3K $22.48 Direct F11
holding PDCO Employee Stock Options 5.54K Sep 30, 2021 Common Stock 5.54K $39.23 Direct F12
holding PDCO Employee Stock Options 13.9K Sep 30, 2021 Common Stock 13.9K $47.51 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired by Reporting Person pursuant to the Patterson Companies, Inc. Employee Stock Purchase Plan.
F2 Includes an aggregate of 17,202 restricted stock units ("RSUs") awarded on 7/1/2017, 8/7/2017, 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Patterson Companies, Inc. Amended and Restated 2015 Omnibus Incentive Plan ("Plan"). The RSUs vest contingent upon continued employment as follows: 8,098 units vest on 7/1/2022, 191 units vest on 8/7/2022, 2,515 units vest on 7/1/2023, 4,773 units vest on 7/14/2023 and 1,625 units vest on 7/1/2024.
F3 Includes 14,410 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the RSU equivalents will automatically convert into shares of common stock.
F4 Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through May 21, 2021.
F5 Stock options granted pursuant to the Plan on 7/1/2021.
F6 Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
F7 Stock options granted pursuant to the Plan on 7/14/2020.
F8 Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
F9 Stock options granted pursuant to the Plan on 7/1/2019.
F10 Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
F11 Stock options granted pursuant to the Plan on 7/1/2018.
F12 Stock option granted pursuant to the Plan on 8/7/2017.
F13 Stock option granted pursuant to the Plan on 7/1/2017.